SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-20-103893
Filing Date
2020-04-10
Accepted
2020-04-10 16:38:20
Documents
14

Document Format Files

Seq Description Document Type Size
1 PRER14A d853876dprer14a.htm PRER14A 2967407
2 GRAPHIC g853876dsp151.jpg GRAPHIC 89175
3 GRAPHIC g853876dsp152.jpg GRAPHIC 98303
4 GRAPHIC g853876g01a11.jpg GRAPHIC 38681
5 GRAPHIC g853876g02b11.jpg GRAPHIC 29737
6 GRAPHIC g853876g02x22.jpg GRAPHIC 35661
7 GRAPHIC g853876g04c11.jpg GRAPHIC 34514
8 GRAPHIC g853876g16h13.jpg GRAPHIC 74306
9 GRAPHIC g853876g31i74.jpg GRAPHIC 50020
10 GRAPHIC g853876g36v22.jpg GRAPHIC 88634
11 GRAPHIC g853876g37g11.jpg GRAPHIC 48890
12 GRAPHIC g853876g37m02.jpg GRAPHIC 44112
13 GRAPHIC g853876g38m11.jpg GRAPHIC 53305
14 GRAPHIC g853876g38v11.jpg GRAPHIC 56156
  Complete submission text file 0001193125-20-103893.txt   3946578
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-36510 | Film No.: 20787016
SIC: 2834 Pharmaceutical Preparations